4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE, MN
Stockholders Approve Amendments to Equity Incentive and Purchase Plans
Reports Landmark Accomplishments, Advancing Toward FDA Approval of First-Of-Its-Kind Fully Implanted Cochlear Implant
Board Appointment - Charles S. McKhann Joins Envoy Medical, Inc.
Annual Report to Security Holders
Envoy Medical, Inc. Dismisses Grant Thornton as Independent Auditor
Financial Results, Press Release
Regains Compliance with Nasdaq Listing Requirement
Announces Closing of Up to $78.0 Million Upsized Public Offering
Q1
Amended Annual Report
FY 2025
Q3
Q2
FY 2024
Prospectus filed pursuant to Rule 424(b)(4)
Effectiveness Notice
Amended Registration Statement for Securities
S-1
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
S-1MEF
Post-Effective Amendment to Registration Statement
Correspondence